Biomarkers in heart failure: from the bedside back to biology

1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cle-land JG, Coats AJ et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–200. DOI: 10.1093/eurheartj/ehw12810.1093/eurheartj/ehw12827206819Open DOISearch in Google Scholar

2. Katz AM, Konstam MA, The Neurohormonal Response in Heart Failure: Functional Signaling in Katz AM, Konstam MA, Geart Failure: Patophysiology, Molecular Biology and Clinical Managemeny, 2th ed, Lippincott Williams & Wilkins, Philadelphia 2009, pg. 89-133.Search in Google Scholar

3. WHO International Programme on Chemical Safety. Biomarkers in Risk Assessment: Validity and Validation. 2001. Retrieved from http://www.inchem.org/documents/ehc/ehc/ehc222.htmSearch in Google Scholar

4. Braunwald E. Biomarkers in Heart Failure. N Engl J Med 2008;358:2148-59. DOI: 10.1056/NEJMra080023910.1056/NEJMra080023918480207Open DOISearch in Google Scholar

5. Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, et al. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2017;135(22):e1054-e91. DOI: 10.1161/CIR.000000000000049010.1161/CIR.000000000000049028446515Open DOISearch in Google Scholar

6. Pop C, Crişan GC, Loghin F, Mogoşan CI. Advances in the detection and quantification of candidate and established biomarkers in heart failure. Rev Romana Med Lab. 2013;21(3):255-65. DOI: 10.2478/rrlm-2013-002910.2478/rrlm-2013-0029Open DOISearch in Google Scholar

7. Zdrenghea DT, Ilea M, Zdrenghea MD, Sitar-Tǎut AV, Pop D. The Effects of Maximal and Submaximal Exercise Testing on NT-proBNP Levels in Patients with Systolic Heart Failure. Rev Romana Med Lab. 2014;22(1):25-33. DOI: 10.2478/rrlm-2014-000810.2478/rrlm-2014-0008Open DOISearch in Google Scholar

8. Goidescu CM, Anton FP, Leucuța DC, Mircea PA, Vida-Simiti LA. Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients. Rev Romana Med Lab. 2016;24(4):399-412. DOI: 10.1515/rrlm-2016-003510.1515/rrlm-2016-0035Search in Google Scholar

9. Lupu A, Lupu S, Agoston-Coldea L. Is galectin-3 a promoter of ventricular dysfunction?. Rev Romana Med Lab. 2018;26(1):21-36. DOI: 10.2478/rrlm-2018-000110.2478/rrlm-2018-0001Open DOISearch in Google Scholar

10. Iliesiu A, Campeanu A, Marta D, Parvu I, Gheorghe G. Uric Acid, Oxidative Stress and Inflammation in Chronic Heart Failure with Reduced Ejection Fraction. Rev Romana Med Lab. 2015;23(4):397-405. DOI: 10.1515/rrlm-2015-003910.1515/rrlm-2015-0039Search in Google Scholar

11. Antohi EL, Tatu Chitoiu G, Ambrosy AP, Coman IM, Vinereanu D, Collins SP et al. Rationale and Design of a Prospective, Multicenter, Observational Study Evaluating Iron Deficiency in Patients Hospitalized for Heart Failure (FERIC-RO). Rev Romana Med Lab. 2018;26(3):271-81. DOI:10.2478/rrlm-2018-002210.2478/rrlm-2018-0022Open DOISearch in Google Scholar